Proteomic profiling of lung diffusion impairment in the recovery stage of SARS‐CoV‐2–induced ARDS
Clinical and Translational Medicine, 2022
García‐Hidalgo M., González J., Benítez I., Carmona P., Santisteve S., Moncusí‐Moix A., Gort‐Paniello C., Rodríguez‐Jara F., Molinero M., Perez‐Pons M., Torres G., Caballero J., Barberà C., Tedim A., Almansa R., Ceccato A., Fernández‐Barat L., Ferrer R., Garcia‐Gasulla D., Menéndez R., Motos A., Peñuelas O., Riera J., Bermejo‐Martin J., Torres A., Barbé F., de Gonzalo‐Calvo D.,
Disease area | Application area | Sample type | Products |
---|---|---|---|
Infectious Diseases | Pathophysiology | Plasma | Olink Target 96 |
Abstract
No abstract (letter to editor format).